🔥Excited to share - Abstract accepted at #AHA2023 #CardioTwitter GlycA predicts CAC incidence and progression ELZA-Brasil cohort Grateful Marcio S Bittencourt Giu Rhanderson Cardoso Raul Santos Isabela Bensenor Paulo Lotufo Peter Toth Steven R. Jones

Outstanding work on calculated cardiovascular risk in the brazilian population from my friend Fernando Cesena sciencedirect.com/science/articl…

☝️All patients receiving statins (regardless of dose) should be associated with ezetimibe 👉Low cost 👉No side effects 👉20% LDLc reduction

A very special moment #AHA23, finally met in person most of our #ELSAbrasil team!! Giu Marcio S Bittencourt Rhanderson Cardoso Paulo Lotufo Dr. Isabela Bensenor

Early identification of oesophageal lesions after atrial fibrillation ablation to prevent atrio-oesophageal fistula academic.oup.com/eurheartj/arti… #Epeeps

#metaanalysis of 5,727 patients with chest pain referred for cath randomized to CCTA vs cath-first. CCTA was linked to lower rates of revasc and stroke compared to cath-first approach #AHAJournals ahajournals.org/doi/10.1161/CI… Jiwon Kim, MD

Coronary CTA before planned invasive diagnostic cath might be routine for chronic CAD patients. Doing a CTA in patients who would otherwise undergo cath is not only safe but it is also associated with more selective revascularizations and lower stroke rates!

A diagnostic test can only have clinical implications if it leads to changes in patient management. Our recent meta-analysis shows the changes in medications that occur after cardiac CT. authors.elsevier.com/c/1iTSL6tu1iBP…

🆕 The 2024 Statistical Update is available now! Heart disease remains the leading cause of death in U.S., yet fewer than half of adults surveyed knew it was their biggest health threat. Get the latest data here: spr.ly/6017TdrOB

LDL-C–Lowering Therapies for Adults and Children With Homozygous Familial Hypercholesterolemia: Challenges and Successes | Circulation ahajournals.org/doi/10.1161/CI… Huge progress how to guarantee access? Amit Khera Khurram Nasir

Dengue outbreaks can affect 390 million persons yearly. In a trial involving 16,235 persons in Brazil, the live, attenuated, tetravalent Butantan vaccine was efficacious in all age groups at 2 years. Read the full trial results: nej.md/3vTJ3Qu

Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults | NEJM nejm.org/doi/full/10.10… Proud and inspired by Brazilian scientists and investigators !

1/ In 2021, 1.7M global deaths were attributed to diabetes, according to the 2024 Statistical Update, which also found that newer therapies proven to lower CVD risk remain underused. Get the latest data published in @CIRCAHA: spr.ly/6015nUVdS ✍🏼 Seth Martin

1/ Hypertension, obesity & other risk factors continue to contribute to high rates of heart disease and stroke worldwide, including in the US, where annual CVD deaths are approaching 1M. Get the latest data published in @CIRCAHA: spr.ly/6013nUkLc ✍🏼 Seth Martin

These 2 weeks have been intensive but rewarding, hope I have contributed with a drop of water on the big ocean of preventive cardiology. Time to implement the knowledge !

👏👏👏👏 Marcio S Bittencourt

1/ The 2024 Statistical Update is your comprehensive look at US and global data on heart and brain health, and an analysis of the core behaviors and conditions that affect CVD risk. Get the latest data published in @CIRCAHA: spr.ly/6014nUbzO ✍🏼 Seth Martin

❤️‍🔥🩸 ➡️What is the transfusion threshold in AMI with anemia? Happy to share our meta-analysis! #MINT Marcio S Bittencourt Lara Melo Soares Pinho de Carvalho Allêh Nogueira Douglas Mesadri Gewehr Giu Rhanderson Cardoso 10.36660/abc.20240158 Arquivos SBC Circulation Sunil V. Rao J Dawn Abbott @docjohanne Andrew M. Goldsweig, MD, MS

#AHA24 Prior studies: ⬆️vol. physical act (PA) linked ⬆️CAC in suggesting early atherosclerosis Our findings: ⬆️Vol. PA was 🚫 linked w/ ⬆️CAC in asympt w/o CVD ELSA-Brasil cohort Longitudinal athlete-level data is lacking Thx my mentor Marcio S Bittencourt and all ELSA-Brasil

📣: Fueled by ongoing increases in high blood pressure, obesity and other major risk factors, CVD remains leading cause of death as key health risk factors continue to rise The 2025 Statistics Update is now available.